CELL INTELLIGENCE · 肿瘤细胞治疗研究

用于乳腺癌治疗的可注射水凝胶：从肿瘤微环境响应性与主动靶向药物递送到免疫治疗与诊疗一体化

Injectable Hydrogels for Breast Cancer Therapy: From Tumor Microenvironment-Responsive and Actively Targeted Drug Delivery to Immunotherapy and Theran

乳腺癌管理中的 CAR-T 细胞治疗：拓展视野并克服血液系统肿瘤之外的挑战

CAR-T cell therapy in breast cancer management: expanding horizon and overcoming challenges beyond hematologic cancers.

AI 驱动的乳腺癌 CRISPR 策略：类器官建模、适应性编辑与精准递送

AI-driven CRISPR strategies in breast cancer: Organoid modeling, adaptive editing, and precision delivery.

HER2+/ER+乳腺癌预后 15 基因特征谱的开发与验证

Development and validation of a prognostic 15-gene signature for stratifying HER2+/ER+ breast cancer.

这是首个对 HER2+/ER+肿瘤进行分层的研究。总体而言，来自不同队列的初步结果显示，HER2+/ER+肿瘤中存在两个不同的亚组，可通过一个 15 基因特征进行区分。我们的发现可能有助于指导未来针对 HER2+/ER+ BC 的精准疗法的开发。

三阴性乳腺癌免疫治疗的进展与展望

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.